Article Details

NeoImmuneTech Receives US FDA IND Clearance for Pilot Study of NT-I7 (efineptakin alfa) in ...

Retrieved on: 2021-02-23 12:00:00

Tags for this article:

Click the tags to see associated articles and topics

NeoImmuneTech Receives US FDA IND Clearance for Pilot Study of NT-I7 (efineptakin alfa) in .... View article details on hiswai:

Excerpt

“With no anti-viral therapies available to treat PML, the only possibility for survival is to restore the antiviral immune response,” said Dr. Cortese.

Article found on: www.biospace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up